1-4 of 4
Celia Garr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of the Combination of Azacitidine (AZA) with MEC (Mitoxantrone, Etoposide and Cytarabine) Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia (AML): Early Results

Rebecca B Klisovic, MD, Hongyan Wang, Alison Walker, MD, Katherine Walsh, MD, Sumithira Vasu, MBBS, Ramiro Garzon, MD, Steven M. Devine, MD, Jiang Wang, Celia Garr, RN, Adam Norris, John C. Byrd, MD, Michael R. Grever, MD, William Blum, MD, Kenneth K. Chan, Ph.D, Guido Marcucci, MD
Journal: Blood
Blood (2012) 120 (21): 3616.
https://doi.org/10.1182/blood.V120.21.3616.3616
Published: 2012
Journal Articles

Priming of Mir-181a in Acute Myeloid Leukemia (AML) to Increase Chemosensitivity: A Phase I Trial of Lenalidomide (LEN) Followed by Idarubicin and Cytarabine.

William Blum, MD, Rebecca B Klisovic, MD, Alison Walker, MD, Sebastian Schwind, MD, Yao Jiang, Jiang Wang, Mitch Phelps, PhD, Susan Geyer, PhD, Steven M. Devine, MD, Kathy Walsh, MD, Sumithira Vasu, MBBS, John P. Curfman, Larry Schaaf, PhD, Celia Garr, RN, Cheryl Kefauver, RN, John C. Byrd, MD, Michael R. Grever, MD, Ramiro Garzon, MD, Guido Marcucci, MD
Journal: Blood
Blood (2012) 120 (21): 2619.
https://doi.org/10.1182/blood.V120.21.2619.2619
Published: 2012
Journal Articles

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia

Clinical Trials & Observations
William Blum, Sebastian Schwind, Somayeh S. Tarighat, Susan Geyer, Ann-Kathrin Eisfeld, Susan Whitman, Alison Walker, Rebecca Klisovic, John C. Byrd, Ramasamy Santhanam, Hongyan Wang, John P. Curfman, Steven M. Devine, Samson Jacob, Celia Garr, Cheryl Kefauver, Danilo Perrotti, Kenneth K. Chan, Clara D. Bloomfield, Michael A. Caligiuri, Michael R. Grever, Ramiro Garzon, Guido Marcucci
Journal: Blood
Blood (2012) 119 (25): 6025–6031.
https://doi.org/10.1182/blood-2012-03-413898
Published: 2012
Includes: Supplemental data
Journal Articles

Phase 1 Trial of Decitabine and Bortezomib in High Risk Acute Myeloid Leukemia (AML)

William Blum, MD, Rebecca B. Klisovic, MD, Ramiro Garzon, MD, Alison Walker, MD, Sebastian Schwind, MD, Shujun Liu, PhD, Larry Schaaf, PhD, Celia Garr, RN, Steven M. Devine, MD, Michael R. Grever, MD, John C. Byrd, MD, Guido Marcucci, MD
Journal: Blood
Blood (2010) 116 (21): 3293.
https://doi.org/10.1182/blood.V116.21.3293.3293
Published: 2010